Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What CAGR And Valuation Are Anticipated For The Pertussis Vaccine Market?

The market size for the pertussis vaccine has consistently expanded over the past few years. From 2024 to 2025, the projection indicates a rise from $5.5 billion to $5.65 billion, with a compound annual growth rate (CAGR) of 2.9%. Factors that contributed to the growth in the historic period include the prevalence of the disease, implementation of immunization programs, pediatric vaccination practices, and regulatory approvals.

In the coming years, the market size for the pertussis vaccine is anticipated to show consistent expansion. It’s projected to escalate to “$6.49 billion by 2029, with a compound annual growth rate (CAGR) of 3.5%. The surge over the forecast period can be accounted to factors such as booster vaccination, maternal immunization, immunization for healthcare workers, and worldwide health initiatives. During the forecast period, prominent trends will comprise personalized immunization schedules, combined vaccines, initiatives for vaccine equality, and the use of digital health in immunization.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Industry Forces Are Driving The Pertussis Vaccine Market Forward?

The pertussis vaccine market is witnessing significant growth due to an increase in childbirth rates. The process of delivering a child, also known as childbirth, signifies the end of pregnancy and the start of a new life outside the womb. The primary use of the pertussis vaccine is for children as it offers them protection against severe and possibly fatal diseases like whooping cough. A report by the Centers for Disease Control and Prevention, a public health organization based in the US, stated that in January 2023, there was a 1% rise in registered births, reaching a total of 3,664,292, in comparison to the previous year in the United States. Therefore, it can be presented that the increasing rate of childbirth is fueling the growth of the pertussis vaccine market.

What Segmentation Insights Are Provided In The Pertussis Vaccine Market Research?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Which Notable Trends Are Transforming The Pertussis Vaccine Market Outlook?

Leading firms in the pertussis vaccine market are creating unique drugs and obtaining official approvals to maintain their market stature. For instance, GSK plc., a pharmaceutical and biotech company based in the UK, disclosed in October 2022 that the U.S. Food and Drug Administration (FDA) gave approval for BOOSTRIX. This vaccine is a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). Used during pregnancy, it offers protection against pertussis, also known as whooping cough, in newborn infants through a single injection in the upper arm muscle. Evidently safe and beneficial for expectant mothers and their offspring, Boostrix is also effective in averting pertussis, even in its severe forms.

Which Firms Are Driving Innovation Within The Pertussis Vaccine Market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model